Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Receivables - Net (2023 - 2025)

Historic Receivables - Net for Beta Bionics (BBNX) over the last 3 years, with Q3 2025 value amounting to $11.7 million.

  • Beta Bionics' Receivables - Net changed N/A to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.7 million, marking a year-over-year change of. This contributed to the annual value of $12.1 million for FY2024, which is 16951.49% up from last year.
  • Latest data reveals that Beta Bionics reported Receivables - Net of $11.7 million as of Q3 2025.
  • Beta Bionics' 5-year Receivables - Net high stood at $12.1 million for Q4 2024, and its period low was $4.5 million during Q4 2023.
  • In the last 3 years, Beta Bionics' Receivables - Net had a median value of $11.5 million in 2025 and averaged $9.8 million.
  • The largest annual percentage gain for Beta Bionics' Receivables - Net in the last 5 years was 16951.49% (2024), contrasted with its biggest fall of 16951.49% (2024).
  • Over the past 3 years, Beta Bionics' Receivables - Net (Quarter) stood at $4.5 million in 2023, then soared by 169.51% to $12.1 million in 2024, then fell by 3.57% to $11.7 million in 2025.
  • Its last three reported values are $11.7 million in Q3 2025, $11.5 million for Q2 2025, and $9.2 million during Q1 2025.